The Kingston Whig-Standard
9-16
Aurora Cannabis reiterates FY27 Q2 sequential net revenue and adjusted EBITDA growth outlook after Safari Flower deal
Aurora Cannabis said it expects sequential growth in fiscal 2027 second-quarter net revenue and adjusted EBITDA. The company said Safari Flower Company, after receiving EU-GMP certification, is expected to add incremental net revenue and adjusted EBITDA. Aurora also cited continued strength in higher-margin international markets, including Germany and Poland, as it targets profitable growth abroad.